FREE SHIPPING ON ALL ORDERS OVER $99 Need help? Text us and our team of experts will reply in minutes: +1 (972) 919-0219 FREE SHIPPING ON ALL ORDERS OVER $99 Need help? Text us and our team of experts will reply in minutes: +1 (972) 919-0219 FREE SHIPPING ON ALL ORDERS OVER $99 Need help? Text us and our team of experts will reply in minutes: +1 (972) 919-0219 FREE SHIPPING ON ALL ORDERS OVER $99 Need help? Text us and our team of experts will reply in minutes: +1 (972) 919-0219

BPC-157 and Nitric Oxide: Exploring the Research

A review of published research examining BPC-157’s interaction with nitric oxide pathways and gastrointestinal biology mechanisms.
⚠ Research Use OnlyNot for Human or Animal Consumption

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. It is one of the most studied peptides in the preclinical literature, with a research record spanning over 30 years and hundreds of published studies. Among its most consistently observed effects is the modulation of nitric oxide (NO) signalling — a finding that may underlie many of its reported actions in tissue repair and vascular biology.

Nitric Oxide in Biology

Nitric oxide is a gaseous signalling molecule produced by nitric oxide synthase (NOS) enzymes from the amino acid L-arginine. Three isoforms of NOS exist: neuronal NOS (nNOS), endothelial NOS (eNOS), and inducible NOS (iNOS). eNOS-derived NO is the primary regulator of vascular tone — it causes smooth muscle relaxation and vasodilation, and plays a central role in angiogenesis and endothelial function.

Dysregulation of NO signalling is implicated in a wide range of pathological conditions, including cardiovascular disease, inflammatory bowel disease, and impaired wound healing. Compounds that modulate NO production or bioavailability are therefore of significant research interest.

BPC-157’s Interaction with NO Pathways

The research group of Sikiric and colleagues at the University of Zagreb has published extensively on BPC-157’s interaction with NO systems. Their studies in rodent models have demonstrated that BPC-157 can counteract the effects of both NO overproduction (induced by NOS activators such as L-arginine) and NO deficiency (induced by NOS inhibitors such as L-NAME).

“BPC-157 appears to act as a NO system modulator, capable of both upregulating and downregulating NO production depending on the prevailing physiological context — a property that distinguishes it from simple NO donors or inhibitors.”

This bidirectional modulation is particularly interesting from a research perspective. In models of L-NAME-induced hypertension (where NO is pharmacologically depleted), BPC-157 has been shown to attenuate the hypertensive response and preserve endothelial function. Conversely, in models of septic shock (where iNOS-derived NO overproduction contributes to hypotension), BPC-157 has been shown to stabilise blood pressure.

Angiogenesis and Wound Healing

One of the most consistently replicated findings in BPC-157 research is its ability to promote angiogenesis — the formation of new blood vessels — in wound healing models. This effect is likely mediated, at least in part, through eNOS-dependent NO production. BPC-157 has been shown to upregulate eNOS expression and VEGF production in endothelial cells, both of which are required for new vessel formation.

In tendon and muscle injury models, BPC-157 treatment has been associated with accelerated vascularisation of the repair tissue, which is thought to contribute to the faster healing observed in these studies. The peptide has also been shown to promote the outgrowth of new vessels from existing capillaries in in-vitro angiogenesis assays.

The Gut-Brain Axis

BPC-157 was originally identified in gastric juice, and its effects on gastrointestinal tissue have been extensively studied. The gut is richly innervated and contains a dense network of NO-producing neurons (nitrergic neurons) that regulate motility, secretion, and mucosal blood flow. BPC-157’s ability to modulate NO signalling in the gut may contribute to its observed effects on intestinal healing and motility in animal models.

BPC-157 is available from The Bio Edit in vial, capsule, and combination blend formats. All products are for laboratory and in-vitro research purposes only.

Conclusion

The interaction between BPC-157 and nitric oxide signalling represents one of the most mechanistically interesting aspects of this peptide’s research profile. Its apparent ability to modulate NO production bidirectionally — upregulating it in conditions of deficiency and downregulating it in conditions of excess — distinguishes it from simpler pharmacological tools and makes it a valuable compound for researchers studying NO-dependent processes in vascular biology, tissue repair, and gut physiology.

In This Article